UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 320

Sortiert nach

Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation

Journal of controlled release, 2021-08, Vol.336, p.192-206

2021

Volltextzugriff (PDF)

The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine

Clinical pharmacology and therapeutics, 2017-09, Vol.102 (3), p.529-536

2017

Volltextzugriff (PDF)

Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges

The international journal of tuberculosis and lung disease, 2018-02, Vol.22 (2), p.125

2018

Volltextzugriff (PDF)

Time delay measurements: estimation of the error budget

Metrologia, 2019-06, Vol.56 (3), p.35004

2019

Volltextzugriff (PDF)

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics

AIDS (London), 2012-07, Vol.26 (12), p.1529-1533

2012

Volltextzugriff (PDF)

Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda

Journal of antimicrobial chemotherapy, 2015-12, Vol.70 (12), p.3317-3322

2015

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro-In Vivo Extrapolation Model

Clinical pharmacology and therapeutics, 2012-10, Vol.92 (4), p.494-502

2012

Volltextzugriff (PDF)

Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)

Journal of antimicrobial chemotherapy, 2015-11, Vol.70 (11), p.3096-3099

2015

Volltextzugriff (PDF)

P05-41 Simulations of antibiotics in dairy cattle in PKSim: a case study of sulfadiazine and trimethoprim

Toxicology letters, 2024-09, Vol.399, p.S147-S148

2024

Volltextzugriff (PDF)

P05-23 Learning by doing: modelling and simulation for risk assessment in the open-source Open Systems Pharmacology Suite (PK-Sim® and MoBi®)

Toxicology letters, 2024-09, Vol.399, p.S140-S141

2024

Volltextzugriff (PDF)

P19-78 Simulating chronic exposure to DEHP with an open-source PBK model: first steps towards aggregate exposure with PK-Sim

Toxicology letters, 2024-09, Vol.399, p.S285-S286

2024

Volltextzugriff (PDF)

P05-43 What does it take to make a PBK for a pesticide in a NGRA framework? Evaluation of the kinetic space of pesticides and how to model it using open-source tools

Toxicology letters, 2024-09, Vol.399, p.S148-S148

2024

Volltextzugriff (PDF)

P19-76 Generic PBK model comparisons: case study methyl eugenol and d-limonene

Toxicology letters, 2024-09, Vol.399, p.S285-S285

2024

Volltextzugriff (PDF)

Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling

British journal of pharmacology, 2014-09, Vol.171 (17), p.3963-3979

2014

Volltextzugriff (PDF)

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

Journal of antimicrobial chemotherapy, 2008-04, Vol.61 (4), p.919-924

2008

Volltextzugriff (PDF)

Matrix model and β-deformed = 4 SYM

The journal of high energy physics, 2009-12, Vol.2009 (12), p.043-43

2009

Volltextzugriff (PDF)

S10-02 New Approach Methodologies (NAMs): a quantitative in vitro to in vivo extrapolation case study with perfluorinated compounds

Toxicology letters, 2024-09, Vol.399, p.S24-S24

2024

Volltextzugriff (PDF)

Gait characteristics of persons with chronic low back pain

Gait & posture, 2009, Vol.30, p.S28-S28

2009

Volltextzugriff (PDF)

2002 SLC28A2 65C>T PREDICT SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HEPATITIS C TREATED WITH INTERFERON AND RIBAVIRIN, CONSIDERING ALL HCV GENOTYPE AND GENOTYPE 1/4

Journal of hepatology, 2010, Vol.52, p.S463-S463

2010

Volltextzugriff (PDF)

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy-the combined test

Prenatal diagnosis, 1999-04, Vol.19 (4), p.360-363

1999

Volltextzugriff (PDF)

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

AIDS (London), 2010-04, Vol.24 (7), p.1064-1066

2010

Volltextzugriff (PDF)

746

The journal of pain, 2007-04, Vol.8 (4), p.S37-S37

2007

Volltextzugriff (PDF)

(746): Effects of extended-release tramadol on osteoarthritis pain in the elderly

The journal of pain, 2007, Vol.8 (4), p.S37-S37

2007

Volltextzugriff (PDF)

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens

Journal of antimicrobial chemotherapy, 2011-09, Vol.66 (9), p.2092-2098

2011

Volltextzugriff (PDF)

A multisystem investigation of raltegravir association with intestinal tissue: implications for pre-exposure prophylaxis and eradication

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3275-3281

2014

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(247)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(6)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation

The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine

Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges

Time delay measurements: estimation of the error budget

Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics

Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda

Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro-In Vivo Extrapolation Model

Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)

P05-41 Simulations of antibiotics in dairy cattle in PKSim: a case study of sulfadiazine and trimethoprim

P05-23 Learning by doing: modelling and simulation for risk assessment in the open-source Open Systems Pharmacology Suite (PK-Sim® and MoBi®)

P19-78 Simulating chronic exposure to DEHP with an open-source PBK model: first steps towards aggregate exposure with PK-Sim

P05-43 What does it take to make a PBK for a pesticide in a NGRA framework? Evaluation of the kinetic space of pesticides and how to model it using open-source tools

P19-76 Generic PBK model comparisons: case study methyl eugenol and d-limonene

Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

Matrix model and β-deformed = 4 SYM

S10-02 New Approach Methodologies (NAMs): a quantitative in vitro to in vivo extrapolation case study with perfluorinated compounds

Gait characteristics of persons with chronic low back pain

2002 SLC28A2 65C>T PREDICT SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HEPATITIS C TREATED WITH INTERFERON AND RIBAVIRIN, CONSIDERING ALL HCV GENOTYPE AND GENOTYPE 1/4

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy-the combined test

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

746

(746): Effects of extended-release tramadol on osteoarthritis pain in the elderly

Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens

A multisystem investigation of raltegravir association with intestinal tissue: implications for pre-exposure prophylaxis and eradication

Suchergebnisse filtern